From: Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
 | Group 1 | Group 2 |
---|---|---|
N | 111 | 76 |
Age (years) ÷ mean (SD) | 60.7(11.3) | 57.98(11.03) |
Male % | 57.6 | 34.2 |
BMI (kg/m2) ÷ mean (SD) | 22.14(4,33) | 21.92(3,8) |
FEV1/FVCa | 0.56(0.16–0.68) | 0.57 (0.26–0.69) |
FEV1% Predicteda | 65(18–78) | 65(25–77) |
FVC (%)a | 66(12)(1.66–5,12) | 60(11,9)(1.66–5.12) |
MRC (score)a | 2(0–4) | 2(0–4) |
CAT (score)a | 28(4–40) | 15(5–40) |
Current/former/non smoker (%) | 34.2/10.8/54.05 | 22.4/10.8/64.5 |
Pack/year÷ (years) mean (SD) | 14.48(23.75) | 8.78(13.48) |